Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
Johnson & Johnson (NYSE: JNJ) will participate in the SVB Securities Global Biopharma Conference on Wednesday, February 15th. Biljana Naumovic, Worldwide Vice President, Oncology and Peter Lebowitz, Global Therapeutic Head, Oncology will represent the Company in a virtual session scheduled at 1:00 p.m. (Eastern Time).
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005064/en/
SOURCE: Johnson & Johnson
Investor Contact: RA-JJCUS-InvestorRel@ITS.JNJ.com Media Contact: Jake Sargent (732) 524-1090
COMTEX_422889941/1006/2023-01-18T16:30:00